CX3CR1 is an important chemokine receptor expressed on the surface of microglia and blood leukocytes, including monocytes. Signalling through this receptor influences the immune activity of microglia and monocyte trafficking into the central nervous system (CNS) in several neurological diseases. During experimental herpes simplex virus 1 (HSV-1) encephalitis (HSE), CX3CR1 deficiency has been reported to exacerbate the outcome of the disease. However, the precise contribution of CX3CR1 expressed in resident cells of the CNS or peripheral monocytes in protection against HSE remains unclear. To dissect the role of CX3CR1 during HSE, we reconstituted irradiated C57BL/6 WT and CX3CR1
INTRODUCTION
Herpes simplex virus 1 (HSV-1) encephalitis (HSE) is the most frequent sporadic and potentially fatal form of viral encephalitis in Western countries. Although the virus infects a high percentage of the population, the incidence of HSE is estimated to be 1/250 000 individuals per year [1, 2] . HSE causes severe neuroinflammation and impairment of neurological functions leading to multiple clinical features including altered consciousness, abnormal behaviour and localized neurological findings such as seizure and paralysis. Despite the use of intravenous acyclovir aimed at blocking virus replication, the mortality rate associated with HSE is still high (i.e. 20-30 %) with the majority of surviving patients developing severe neurological sequelae [3, 4] . Our understanding of the pathogenesis of HSV-1 infection of the central nervous system (CNS) remains incomplete and elusive. It is believed that both direct virus-induced and indirect immune-mediated mechanisms contribute to CNS damage [5, 6] .
The control of HSV-1 infection in the CNS is dependent on cellular immune response mediated by local tissue macrophages, namely microglia. It was reported that microglia can control virus replication in the brain by producing inflammatory cytokines and chemokines such as IL-6, IL1b, type I interferons (IFN-I), C-X-C motif ligand 10 (CXCL10), C-C motif ligand 2 (CCL2) and CCL5 [7] [8] [9] [10] . However, overactive immune responses may contribute to the long-term neuropathological sequelae associated with HSE. Indeed, it has been demonstrated that prolonged microglial activation following HSV-1 infection could be detrimental and worsen tissue damage by an overproduction of inflammatory cytokines, nitric oxide and reactive
In the CNS, CX3CR1 is mainly expressed by microglia and to a lesser extent by perivascular macrophages whereas its sole known ligand, fractalkine (CX3CL1), is constitutively expressed by healthy neurons and endothelial cells [17, 18] . This ligand comprises a transmembrane protein that can also be cleaved into a soluble form. The soluble form of CX3CL1 can act as a signalling molecule and bind CX3CR1 expressed by microglia, whereas its membrane-bound form can serve as a cell adhesion molecule for microglia and infiltrating leukocytes during inflammatory episodes [16] . Binding of CX3CL1 to CX3CR1 conveys potent inhibitory inputs to microglia and constitutes a key pathway through which neurons regulate innate immunity in the CNS [16, 19] . Indeed, the CX3CL1/CX3CR1 axis controls microglial effector functions and regulates their neurotoxic properties under inflammatory conditions in order to maintain a quiescent state [16, 20, 21] . Furthermore, the signalling through CX3CR1 participates in the control of production of several cytokines as well as in the regulation of the phagocytic activity of microglia [22] [23] [24] [25] .
In the blood, CX3CR1 is expressed on the surface of leukocytes including monocytes [26, 27] . The relative level of CX3CR1 defines two distinct monocyte subsets in mice: the inflammatory monocytes [which are CX3CR1 low and also express the lymphocyte antigen 6C (Ly6C hi ) and the C-C chemokine receptor 2 (CCR2 + )] and the patrolling monocytes (which are CX3CR1 hi , Ly6C low and CCR2 À ) [26, 28] . Inflammatory monocytes infiltrate inflamed tissues in a CCR2-dependent manner and exert pro-inflammatory responses essential for pathogen containment and debris removal [28] [29] [30] [31] [32] [33] [34] . In contrast, patrolling monocytes are thought to pass through the brain vasculature and infiltrate the CNS in a CX3CR1-dependent manner [16, 33, 35] . It is believed that these cells can exert anti-inflammatory functions and are involved in tissue regeneration following organic insults and replenishment of tissue macrophages [30, 33, 34, [36] [37] [38] .
Using CX3CR1
À/À mice, our group had previously demonstrated that deficiency in the CX3CR1 signalling pathway results in an increased recruitment of inflammatory and patrolling monocytes to the CNS following intranasal infection with HSV-1, which was associated with higher mortality rates compared to wild-type (WT) C57BL/6 controls [39] . However, CX3CR1 expressed on resident cells of the CNS and haematopoietic system is involved in different functions and the relative contribution of this receptor during HSE remains elusive. To delineate how CX3CR1 signalling affects the outcome of HSE, we reconstituted WT C57BL/6 and CX3CR1 À/À mice conditioned by irradiation with CX3CR1
fiWT) and WT (WTfiCX3CR1 À/À ) bone marrow cells, respectively. By using these chimeric mouse models, we evaluated the influence of CX3CR1 signalling in resident cells of the CNS and in circulating leukocytes on the outcome of HSE (survival rates), virus titres and dissemination, cytokine/chemokine levels in the brain, infiltration of blood leukocytes into the CNS as well as blood-brain barrier (BBB) permeability. We report here that the CX3CR1 signalling pathway through resident cells of the CNS (most likely microglia) is involved in the control of HSE and that deficiency in this receptor in haematopoietic cells does not seem to affect the outcome of the disease.
RESULTS
Irradiation followed by bone marrow transplantation induces a strong peripheral chimerism in monocytes The efficiency of the myeloablative process, comprising irradiation and replenishment of the haematopoietic system of recipient mice by newly transplanted cells, was evaluated 8 weeks after transplantation in CX3CR1 À/À mice were not statistically different between groups (3.7±0.4, 3.1±0.4, 3.0±0.5 and 3.4±0.6 %, respectively), indicating that deficiency in CX3CR1 did not alter global monocyte amounts (Fig. 1c) . Detailed evaluation of GFP expression in monocyte subpopulations in CX3CR1 À/À fiWT chimeric mice revealed that levels of Ly6C hi inflammatory (89.5±3.2 %) and Ly6C low patrolling (92.1±2.4 %) monocytes were very similar to those of CX3CR1 À/À animals (92.2±3.6 and 96.2±1.7 %, respectively) (Fig. 1d) . Overall, these data suggest that recipient haematopoietic cells from the monocytic lineage were almost entirely replenished by donor bone marrow cells.
Functional CX3CR1 signalling in resident cells of the CNS is important for mouse survival following HSV-1 infection To examine whether non-functional CX3CR1 signalling in resident cells of the CNS or in the haematopoietic cells affects the outcome of HSE, we generated chimeric mice by the reconstitution of irradiated CX3CR1 À/À and WT mice with WT (WTfiCX3CR1 CX3CR1 expression in resident cells of the CNS is involved in the control of viral replication in the brain during HSE Infectious viral titres were measured in brain homogenates of all groups of mice prior to (day 0) and on days 4, 6, 8 and 10 following intranasal infection with HSV-1. These different time points were selected based on survival curves (Fig. 2) . As shown in Fig. 3 À/À mice (n=14 mice per group) were infected intranasally with HSV-1 (1.2Â10 6 p.f.u. in 20 µl minimal essential medium). Mice were examined carefully twice a day for 20 days, and two obvious signs of sickness or a !20 % weight loss was considered as an endpoint for sacrifice. Results are from one experiment. Survival curves were analysed using a log-rank (Mantel-Cox) test. Statistically significant results compared to those for the corresponding group are indicated as follows: *P<0.05. also be detected on day 8 in the same regions whereas they were no longer visible on day 10 p.i. (data not shown). These results are in line with previous work from our laboratory, which showed that HSV-1 antigens were found in the same anatomical areas [31] . Interestingly, in addition to the brain regions described above, HSV-1 distribution was extended to both the periventricular zone of the hypothalamus and the cerebellum in WTfiCX3CR1
À/À and CX3CR1 À/À mice on day 6 p.i. These data suggest that nonfunctional CX3CR1 signalling in resident cells of the CNS may alter viral containment, which results in a wider viral dissemination.
CX3CR1-deficient signalling in resident cells of the CNS results in an increased pro-inflammatory environment following HSV-1 infection
In order to determine the impact of CX3CR1 deficiency on the production of inflammatory cytokines and chemokines, levels of IL-1b, IL-6, IFN-g, CCL2 and CCL5, which are known to play an important role during HSE [7, 10, 41, 42] , were measured in brain homogenates of WT, CX3CR1
À/À and CX3CR1 À/À mice prior to (day 0) and on days 6, 8 and 10 p.i. Fig. 5 shows that for WT mice, levels of IL-1b, IL-6, IFN-g and CCL2 were significantly increased in brains of animals sacrificed on day 6 p.i. compared to those of their counterparts sacrificed on day 0 [P<0.05 (not indicated)]. Levels decreased thereafter on days 8 and 10 p.i. but remained significantly higher compared to day 0 for IL-1b and CCL2 [P<0.01 (not indicated)]. The expression pattern of these cytokines and chemokines in CX3CR1
À/À fiWT, WTfiCX3CR1 À/À and CX3CR1 fiWT, WTfiCX3CR1 À/À and CX3CR1 À/À animals (four to five mice per group) sacrificed on day 6 p.i. The detection of HSV-1 in brain tissue sections was repeated three times. Brain slices (25 µm thick) were processed for immunohistochemical analyses with a polyclonal rabbit anti-HSV-1/2 primary antibody and an Alexa 594-conjugated chicken anti-rabbit secondary antibody (red), followed by nuclear staining with DAPI (blue). Red-coloured boxes indicate the anatomical location where images were captured. Scale bar, 100 µm.
WTfiCX3CR1
À/À mice) on day 6 p.i. [P<0.05 (not indicated) compared to their counterparts sacrificed on day 0] whereas it remained unchanged following the infection in WT and CX3CR1
À/À
fiWT animals compared to their corresponding cohorts sacrificed on day 0. Importantly, levels of all cytokines and chemokines in the susceptible CX3CR1 À/À and WTfiCX3CR1 À/À animals significantly exceeded those measured in brains of the resistant CX3CR1 À/À fiWT and WT mice on day 6 p.i. [P<0.05 (Fig. 5) ]. These data suggest that CX3CR1 deficiency in resident cells of the CNS, but not in haematopoietic cells, results in uncontrolled cytokine/chemokine production in mouse brain following HSV-1 infection.
CX3CR1 deficiency in resident cells of the CNS results in an increased infiltration of blood leukocytes into the brain following HSV-1 infection
The infiltration of blood leukocytes into the CNS of WT, CX3CR1 À/À , CX3CR1
À/À fiWT and WTfiCX3CR1
À/À mice was evaluated by flow cytometry analyses prior to and on days 4, 6, 8 and 10 p.i. with HSV-1. In our study, the expression levels of CD45 and CD11b were used to distinguish CD45 low /CD11b + from CD45 hi /CD11b + cells, which were attributed to resident microglia and blood-derived leukocytes that infiltrate the CNS, respectively (Fig. 6a) . Neutrophils were discriminated from other blood-derived leukocytes by using the granulocyte marker Ly6G. Finally, monocytes were further differentiated according to Ly6C expression level into Ly6C hi inflammatory and Ly6C low patrolling monocytes, respectively.
Analysis of leukocyte population in the CNS prior to infection showed no significant differences in the proportion of haematopoietic-derived leukocytes and resident microglia between groups. Fig. 6 + infiltrating myeloid cells (dashed circle), neutrophils were selected based on the expression of the granulocyte marker Ly6G, whereas monocyte subsets were discriminated according to Ly6C expression level into Ly6C hi inflammatory and Ly6C low patrolling monocytes. The percentages of (b) infiltrating leukocytes, (c) inflammatory monocytes, (d) patrolling monocytes and (e) neutrophils with respect to total brain leukocytes represent the means±standard deviations of four to five mice per group at each time point. Statistical analyses were performed using one-way ANOVA with Tukey's multiple comparison post-test. Statistically significant differences compared to WT group are indicated as follows: *P<0.05; **P<0.01; ***P<0.001.
Interestingly, significantly higher increases in levels of CD45 hi cells were observed in CX3CR1 À/À [from 8.5±0.8 % prior to infection to 53.9±6.5 %; P<0.001 (Fig. 6b) (Fig. 6b) ] mice compared to WT group. Increased levels observed on day 6 were sustained on day 8 p.i. for both CX3CR1 À/À [50.5±6.5 %; P<0.001 (Fig. 6b)] and WTfiCX3CR1 À/À [47.2±6.4 %; P<0.01 (Fig. 6b) ] animals compared to WT mice. On day 10 p.i., levels of blood leukocytes decreased in all mice without significant differences between groups. Overall, our results indicate that the lack of a CX3CR1 signalling pathway in resident cells of the CNS results in an increased infiltration of blood leukocytes during HSE. Fig. 6(c) shows that levels of Ly6C hi inflammatory monocytes in WT mice were slightly increased on day 4 (from 1.7 ±0.4 % on day 0 to 2.2±0.5 %) and were significantly higher on day 6 (Fig. 6c) ]. In contrast, the level of inflammatory monocytes in CX3CR1 À/À fiWT mice was not statistically different compared to WT. On day 8, percentages of inflammatory monocytes decreased in all mice without significant differences between groups to reach baseline levels on day 10 p.i. These data suggest that the lack of CX3CR1 signalling in resident cells of the CNS results in a higher infiltration of inflammatory monocytes into the brain, whereas its deficiency in blood cells does not appear to influence their trafficking. À/À following the infection, but they reached a peak on day 6 p.i. [P<0.001 and P<0.01 (not indicated), respectively] compared to their counterparts sacrificed on day 0. In addition, this increase was statistically significant in CX3CR1
À/À [6.8±1.4 %; P<0.05 (Fig. 6d) ] compared to WT mice (3.5±0.5 %) but not in group CX3CR1 À/À fiWT (5.4±1.9 %). In WTfiCX3CR1 À/À mice, the infiltration of patrolling monocytes closely mimicked that of WT animals. On day 8 p.i., levels decreased in all knockout groups to reach baseline amounts on day 10. À/À mice, percentages of neutrophils significantly increased on day 6 [from 1.5±0.3 % on day 0 to 9.8±1.4 %, P<0.001 and from 2.8±0.4 to 8.4±1.1 %, P<0.001 (both not indicated), respectively] and were sustained on day 8 p.i. [8.2±1.0 %, P<0.001 and 5.7±1.1 %, P<0.05 (both not indicated), respectively] compared to their counterparts sacrificed on day 0. Importantly, levels of neutrophils were higher in CX3CR1 À/À and WTfiCX3CR1 À/À animals than in WT, particularly on day 8 p.i. [P<0.001 for both groups (Fig. 6e) ]. In CX3CR1 À/À fiWT mice, no differences in neutrophil kinetics and level were observed compared to WT group. Thus, CX3CR1 deficiency in resident cells of the CNS, but not in the haematopoietic cells, results in a higher and sustained infiltration of neutrophils during HSE. Overall, our results mainly suggest that dysfunctional CX3CR1 signalling in resident cells of the CNS results in an increased inflammatory monocyte and neutrophil infiltration into the brain, which may be related to the higher vulnerability seen in mice following HSV-1 infection. In contrast, haematopoietic deficiency in this receptor barely influences the kinetics of leukocyte infiltration since the profile seen in irradiated WT mice reconstituted with CX3CR1 À/À bone marrow cells was very similar to that of WT mice.
Blood leukocytes infiltrate the CNS without breakdown of the BBB
To evaluate whether the infiltration of blood leukocytes into the brain resulted from a functional recruitment or an alteration of the BBB surrounding the CNS vasculature, brain sections were stained for blood protein albumin. Interestingly, there was no immunoreactivity for albumin in the brain parenchyma of anatomical areas in which virus mainly replicated (olfactory bulb and medulla) (Fig. S1 , available in the online Supplementary Material) or any other regions of the CNS (data not shown) on day 0 (negative control), and in animals infected with HSV-1 (on day 6 p.i.) when compared to an ischaemic tissue (positive control). These results suggest that the infiltration of blood leukocytes into the CNS following HSV-1 infection is not related to BBB alterations but might rather be the result of functional recruitment.
DISCUSSION
In the present study, we intended to better evaluate the impact of a deficiency in the CX3CR1 signalling pathway during experimental HSE. As the CX3CL1/CX3CR1 axis could differentially influence the way that resident microglia in the CNS and blood monocytes affect disease outcome, we reconstituted WT and CX3CR1 À/À recipient mice conditioned by irradiation with CX3CR1 À/À and WT bone marrow cells, respectively. By using these chimeric mice, we investigated the relative contribution of CX3CR1 signalling in resident cells of the CNS and blood leukocytes in conferring protection during experimental HSE.
Our results showed that CX3CR1
À/À mice were more susceptible to HSV-1 compared to WT, suggesting that signalling through this receptor plays a beneficial role in the control of HSE. More precisely, CX3CR1 deficiency in resident cells of the CNS rather than in blood leukocytes resulted in higher mortality rates compared to WT. Indeed, transplantation of CX3CR1 À/À recipient mice with WT bone marrow cells (WTfiCX3CR1 /À ) was not sufficient to reduce mortality compared to CX3CR1 À/À mice. Furthermore, deficiency in CX3CR1 in haematopoietic cells (CX3CR1 À/À fiWT) did not increase mortality rates compared to WT mice. These data suggest that transplanted cells reconstitute mainly the haematopoietic cells, which are sensitive to irradiation and for which CX3CR1 signalling did not appear to influence the outcome of HSE.
A protective effect of CX3CR1 signalling disruption was reported in different models of acute brain injury, including ischaemia and spinal cord injury [43] [44] [45] . By contrast, CX3CR1
À/À mice infected with prions had a significant reduction in incubation time associated with reduced survival compared to WT [46] . In neurodegenerative diseases, disruption of the CX3CL1/CX3CR1 axis led to variable results. Deficiency in CX3CR1 in models of Parkinson's disease and amyotrophic lateral sclerosis induced a worsening of neurological outcome [47] . Furthermore, in animal models of experimental autoimmune encephalomyelitis (EAE), CX3CR1
À/À mice exhibited more severe neurologic deficiencies compared to WT [35] . Both protective [48] and worsening [49] outcomes were reported in CX3CR1 À/À mice compared to WT in studies conducted in Alzheimer's disease models. Thus, the role played by the CX3CL1/ CX3CR1 axis in brain pathologies may vary with respect to insult types, as well as animal models and experimental design.
In our study, higher mortality rates were associated with increased infectious viral titres and a wider dissemination of HSV-1 antigens in brains of CX3CR1 À/À and WTfiCX3CR1 À/À animals, suggesting that non-functional CX3CR1 signalling in resident cells of the CNS may compromise the efficient control of viral replication. In this respect, it was shown that CX3CR1 deficiency might alter microglial phagocytic and clearance capacities [19] , which could explain the impaired viral elimination observed in our experiment.
However, it cannot be excluded that higher viral titres in brain homogenates of CX3CR1-deficient mice may be related to a loss of viral containment at the site of inoculation and in the peripheral nervous system. Indeed, it was reported that CX3CR1 is expressed on tissue resident macrophages, a subset of NK cells and T lymphocytes [50, 51] . In addition, these cells are known to be involved in the control of HSV-1 replication at the site of inoculation (nasal, ocular and oral mucosa) and in the trigeminal ganglia [6, 52, 53] . Hence, there is a possibility that CX3CR1 deficiency could alter the immunological functions of tissue resident cells and the recruitment of blood leukocytes to these anatomical sites.
Importantly, increased levels of cytokines and chemokines, as well as an infiltration of inflammatory monocytes and neutrophils, were observed in brain homogenates harvested from CX3CR1
À/À and WTfiCX3CR1 À/À animals compared to WT mice and those carrying the deficiency in haematopoietic cells. These data suggest that signalling through CX3CR1 plays an important role in the control of the inflammatory environment in the CNS during HSE, and that functional signalling via this receptor in the haematopoietic system is not sufficient to maintain an appropriate cytokine-mediated inflammatory response. It is proposed that microglial cells are activated in response to variable neuronal injuries [54] and that CX3CR1 signalling is important for the control of the immune functions and activation state of microglia through mechanisms regulating their cytokine and chemokine release. In vitro studies demonstrated that lipopolysaccharide-induced expression of cytokines such as IL-1b, IL-6, TNF-a and nitric oxide in cultured microglia was efficiently blocked by CX3CL1 stimulation [55, 56] . Furthermore, in vivo studies supported the hypothesis that CX3CR1 signalling in the brain reduced microglial reactivity and maintained adequate cytokine production [57] . Indeed, several models of microglia-induced neurotoxicity demonstrated that CX3CR1 À/À mice exhibited a significantly higher microglial activation than their WT counterparts, which resulted in an overproduction of inflammatory cytokines [16, 47, 58] . In line with these observations, CX3CR1
À/À mice suffering from EAE also showed overproduction of inflammatory cytokines (i.e. TNF-a and IFN-g) in the brain compared to WT. In our experiments, CX3CR1 deficiency in resident cells of the CNS induced higher levels of inflammatory cytokines and chemokines including IL-1b, IL-6, IFN-g, CCL2 and CCL5 when compared to WT. It is suggested that uncontrolled cytokine production during HSE could exacerbate disease severity [5, 6] .
Furthermore, the excessive production of chemokines, such as CCL2 and CCL5, observed in the more susceptible groups could induce the recruitment of peripheral immune cells that in turn may contribute to amplifying the global immune response. Indeed, in the more susceptible CX3CR1 À/À and WTfiCX3CR1 À/À groups, higher levels of infiltrating Ly6C hi inflammatory monocytes occurred compared to resistant CX3CR1 À/À fiWT and WT groups. It is believed that monocyte migration to the CNS following cerebral insults is a hallmark of neuro-inflammation [59, 60] . It has also been shown that these blood-derived macrophages are able to perform effector functions including production of pro-inflammatory cytokines as well as reactive oxygen species and nitric oxide, all of which could be beneficial for microbial clearance [8, 61] . However, uncontrolled infiltration of these cells may result in immune-induced pathology causing disease exacerbation. Neuroinvasive infections caused by several viruses, such as lymphocytic choriomeningitis virus [62] , Theiler's encephalomyelitis virus [63] and West Nile virus [29] , are associated with Ly6C hi inflammatory monocyte infiltration into the CNS, which has been demonstrated to be harmful to the host by ultimately inducing brain damage. In the context of HSE, our results demonstrate that higher level of inflammatory monocytes infiltrate the CNS of CX3CR1 À/À and WTfiCX3CR1 À/À groups compared to WT mice and those carrying receptor deficiency in the haematopoietic system. Therefore, increased mortality rates in mice with a CX3CR1 deficiency in resident cells of the CNS may be partially attributable to an excessive infiltration of this monocyte subset that could amplify the inflammatory environment.
A recent study demonstrated that Ly6C low patrolling monocytes are recruited at later stages of the inflammatory process mediated by Ly6C hi monocytes to perform antiinflammatory functions [34] . As previously shown by our group [31] , these cells enter the CNS of WT mice later during HSE and follow inflammatory monocyte recruitment. Intriguingly, CX3CR1 deficiency in peripheral blood seems to disturb patrolling monocyte trafficking into the CNS, since their infiltration preceded and was higher (although not significantly) than that of WT animals and those harbouring the deficiency in resident cells of the CNS. However, such increase in patrolling monocyte infiltration did not influence mortality rates in this group. Further investigations are thus required to better understand the role and kinetics of infiltration of these cells into the brain and how CX3CR1 modulates their fate during HSE.
As previously described by our group [31] , neutrophils infiltrated the CNS of WT mice during HSE. In CX3CR1 À/À and WTfiCX3CR1 À/À animals, neutrophil infiltration was higher and more sustained compared to CX3CR1 À/À fiWT and WT groups (Fig. 6e) . Thus, excessive infiltration of these cells into the CNS may also contribute to amplify the cerebral immune response and thus worsen disease outcome. In susceptible BALB/c mice, it was reported that neutrophil infiltration into the CNS may be associated with disease exacerbation and death following HSV-1 infection [11] .
NK cells and T lymphocytes, which also likely infiltrate the CNS of mice, may be involved in the control of HSV-1 infection. Thus, it would be of interest to investigate the impact of CX3CR1 deficiency on the recruitment of these leukocytes in our mouse model of HSE, thereby addressing a global picture of blood immune cell implication.
It has been shown that intranasal inoculation of HSV-1 to susceptible SJL mice induced the production of metalloproteinase-9 leading to the degradation of collagen IV, which causes a disruption of BBB integrity and an increased ability of inflammatory leukocytes to infiltrate the CNS [64] . To examine the integrity of the BBB in our mouse model of HSE, we used a qualitative method utilizing the detection of albumin in the CNS parenchyma. Our results showed that despite the important inflammatory response observed in mice carrying CX3CR1 deficiency in resident cells of the CNS, infiltration of peripheral leukocytes into the brain following HSV-1 infection seems to be the result of functional recruitment rather than alteration of the BBB.
One of the limitations in our studies is that the myelo-ablative process, utilizing total body irradiation with a dose of 10 Gy followed by bone marrow transplantation as performed here, can introduce artefacts that result in minimal and non-physiological haematopoietic cell engraftment in the CNS [65] . However, this method was proved effective in allowing a stable and higher chimerism in the blood and bone marrow compared to other myelo-ablative methods such as parabiosis, head-shielded irradiation or chemotherapy [66, 67] .
In addition, CX3CR1 signalling is known to be involved in the regulation of a broad spectrum of functions including survival of developing neurons, synaptic pruning and plasticity, maturation of neuronal connectivity and adult hippocampal neurogenesis [68, 69] . There is thus a possibility that these developmental defects might influence the ability of CX3CR1
À/À mice to control HSV-1 infection in addition to immune responses, and that transplantation of these mice with WT bone marrow cells might not compensate for these alterations.
Overall, our results demonstrate that functional CX3CR1 signalling in resident cells of the CNS (most likely microglia) plays a critical role in the control of viral replication and immune response in a mouse model of intranasal infection with HSV-1. This study establishes that deficiency in CX3CR1 in resident cells of the CNS alters the immune response mediated by cytokines, which may modulate the recruitment of inflammatory monocytes and neutrophils to the brain, likely contributing to disease exacerbation and mortality.
METHODS Animals
Wild-type C57BL/6 male mice were purchased from Charles River Laboratories, Canada and CX3CR1 gfp/gfp(À/À) (B6.129P-Cx3cr1 tm1Litt /J) male mice, which are maintained in a C57BL/6 background, were purchased from the Jackson Laboratory, USA. Animals were acclimated to standard laboratory conditions (12 h light/dark cycle; on at 7 : 15 and off at 19 : 15) and housed three to four per cage.
Irradiation and bone marrow transplantation Chimeric mice with deficient CX3CR1 signalling in resident cells of the CNS or in the haematopoietic cells were generated by transplantation of WT bone marrow-derived cells in irradiated CX3CR1 À/À mice (WTfiCX3CR1 À/À ) or by injection of cells harvested from CX3CR1 À/À mice to irradiated WT animals (CX3CR1 À/À fiWT), respectively. Eight-to nine-week-old WT and CX3CR1 À/ recipient male mice were housed in autoclaved cages with irradiated mouse chow. Mice were treated with 0.2 mg trimethoprim ml À1 and 1 mg sulfamethoxazole ml À1 (SEPTRA; GlaxoSmithKline) of sterile water ad libitum started 1 week before and maintained for 2 weeks after transplantation. WT and CX3CR1 À/À recipient mice were exposed to 10 Gy total body irradiation using a 60 Co source (Theratron-780; MDS Analytical Technologies) [66] . Bone marrow cells from age-and sex-matched WT and CX3CR1 À/À donor mice were aseptically harvested by flushing the femurs and tibias as previously described [31] . Recovered cells [1.5Â10 7 in 200 µl of Dulbecco's PBS (DPBS)] were then injected into the tail vein of recipient mice 24 h following irradiation. To prevent irradiation-induced dehydration, mice received a once-daily injection of 1 ml saline subcutaneously for 1 week [66] .
Flow cytometry procedures for evaluation of chimerism in blood monocytes Blood samples (~120 µl) were withdrawn from the facial vein of CX3CR1 À/À fiWT and WTfiCX3CR1 À/À chimeric mice 8 weeks after transplantation, as well as from age-and sex-matched WT and CX3CR1 À/À controls (n=8 mice per group). Samples were collected in EDTA-coated tubes (Starstedt) to prevent coagulation and prepared for antibody labelling as previously described [31] . Cell suspensions were first incubated on ice for 35 min with purified rat antimouse CD16/CD32 (Mouse Fc Block, clone 2.4 G2; BD Biosciences). After a washing step, cells were labelled with the following rat anti-mouse antibodies for 40 min at 4 C: PECy5-CD45 (clone 30-F11; BD Biosciences), APC-CD115 (clone AF598; eBioscience), PE-Cy7-CD11b (clone M1/70; eBioscience), V450-Ly6C (clone AL21; BD Biosciences) and PE-Ly6G (clone 1A8; BD Pharmingen). Red blood cells were lysed with BD Pharm Lyse (BD Biosciences) for 30 min at room temperature and recovered leukocytes were washed and resuspended in DPBS. Flow cytometry analyses and data acquisition were performed using a BD SORP LSR II and the BD FACSDiva software, respectively.
Experimental procedures
For survival curve experiment, 16-week-old WT, CX3CR1
À/À fiWT and WTfiCX3CR1 À/À mice (n=14 mice per group) were infected intranasally with a viral inoculum consisting in 1.2Â10 6 p.f.u. of HSV-1 clinical strain H25 (grown and passaged in Vero cells) in 20 µl minimal essential medium (MEM) as described elsewhere [41] . HSErelated signs, namely, ruffled fur, ocular swelling, shaking movements, swollen forehead, weight loss and mortality, were monitored twice daily for 20 days. Animals were sacrificed when a !20 % weight loss or a combination of two other obvious sickness signs was observed.
For the determination of infectious viral titres as well as cytokine and chemokine levels in brain homogenates, four to five mice per group were deeply anaesthetized with an intraperitoneal injection of a mixture of ketamine hydrochloride (Bioniche Animal Health) and xylazine (Bimeda) and sacrificed prior to and on days 4, 6, 8 and 10 p.i. by intracardiac perfusion with cold 0.9 % saline. Brains were then harvested and homogenized in 700 µl PBS containing protease (cOmplete) and phosphatase (PhosSTOP) inhibitor cocktails (Roche Applied Science). Samples were stored at À20 C until use.
For immunohistochemistry studies, four to five mice per group were sacrificed prior to and on days 4, 6, 8 and 10 p.i. by intracardiac perfusion with cold 0.9 % saline followed by a 4 % paraformaldehyde solution (pH 7.4) at 4 C. Brains were removed, post-fixed and cut in 25 µm coronal sections as previously described [31] .
Infectious virus titre measurements
Virus titres were determined in brain homogenates by a standard plaque assay. Briefly, monolayers of African green monkey kidney (Vero) cells were inoculated with 100 µl of brain homogenates undiluted and serially diluted with MEM and incubated for 90 min in a 5 % CO 2 humidified incubator at 37 C. The viral suspensions were then removed, and cells were incubated with MEM containing 2 % FBS and 0.4 % SeaPlaque agarose (Lonza) for 72 h. Cells were fixed and stained, and the number of p.f.u. was determined under an inverted microscope. The limit of detection of the plaque assay is 5 p.f.u. (100 µl)
À1 of brain homogenates.
Immunohistochemistry analyses
Free-floating brain sections were washed three times for 15 min in potassium PBS (KPBS; Sigma-Aldrich) and incubated for 30 min in KPBS containing chicken serum (Rockland Immunochemicals), 1 % BSA and 0.4 % Triton X-100 (both from Sigma-Aldrich). Sections were incubated overnight with a polyclonal rabbit anti-HSV-1/2 (anti-infected cell proteins and late structural antigens, diluted 1 : 750) (AbD Serotec) or rabbit anti-albumin (1 : 1000) (Abcam) primary antibodies diluted by one-half in the same buffer solution at 4 C. Sections were then rinsed three times for 15 min and incubated with an Alexa 594-conjugated chicken anti-rabbit secondary antibody (diluted 1 : 1500) (Invitrogen) at room temperature. Finally, nuclear staining was performed using DAPI (diluted to 0.0002 % for 10 min; Molecular Probes). Sections were then rinsed three times for 10 min in KPBS before being mounted onto SuperFrost slides (Fisher Scientific) and coverslipped with Fluoromount-G (SouthernBiotech). Ischaemic tissue used as a positive control for the evaluation of BBB integrity was kindly provided by Dr Serge Rivest (Laval University, Qu ebec, Canada) [70] . Standard fluorescence microscopy images were captured using a Nikon Eclipse 80i microscope (Nikon) equipped with a digital camera (QImaging). Regions of the CNS were identified based on the mouse brain atlas (http://atlas.brain-map.org).
Cytokine and chemokine level measurements Brain homogenates (400 µl) of mice sacrificed prior to and on days 6, 8 and 10 p.i. were centrifuged at 13 000 g for 10 min at 4 C. A volume of 100 µl of the supernatant was used for cytokine and chemokine quantification using a commercial multiplex mouse cytokine magnetic bead-based immunoassay using the Bio-Rad Bio-Plex mouse cytokine group I plex assay (Bio-Rad Laboratories) according to the manufacturer's instructions. Results were analysed with the Bio-Plex system equipped with the Bio-Plex Manager Software v6.0 (Bio-Rad Laboratories).
Flow cytometry analyses
Prior to and on days 4, 6, 8 and 10 p.i., WT, CX3CR1 À/À , CX3CR1 À/À fiWT and WTfiCX3CR1 À/À mice (five animals per group) were deeply anaesthetized and perfused intracardially with ice-cold DPBS without Ca 2+ and Mg 2+ . Brains were then extracted and prepared for immunostaining as previously described [31] . Briefly, brain homogenates were incubated in DPBS supplemented with Liberase TL (Roche Diagnostics) for 1 h at 37 C and filtered through a 70 µm cell strainer (BD Biosciences). After a washing step, cells were centrifuged at 600 g for 40 min in a Percoll gradient (37 and 80 %) (GE Healthcare). The cell ring at the interphase was collected, centrifuged at 300 g for 10 min and washed twice with DPBS plus 2 % FBS. Cells were then incubated with CD16/CD32 on ice followed by 40 min incubation with the same pool of secondary antibodies described above except APC-CD115. Labelled cells were then washed and resuspended in DPBS. Flow cytometry analyses and data acquisition were performed using a BD SORP LSR II and BD FACSDiva software, respectively.
Statistical analyses
Differences in mouse survival rates were compared using a log-rank (Mantel-Cox) test. Differences in infectious virus titres, cytokine and chemokine levels and percentages of blood-derived cells in brain homogenates were evaluated using one-way ANOVA with Tukey's multiple comparison post-test. All statistical analyses were carried out using the GraphPad Prism software program, version 5.00 (GraphPad Software). A P value 0.05 was considered statistically significant.
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